Fostering AI Solutions To Revolutionize Drug Discovery Startups

Post-hype, pre-value: The real AI-pharma shift starts now

AION Labs Launches 2025 Global Call for Applications: Generative AI for Novel Target Combinations

Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players

What to look for in a biotech incubator

Podcast: About Medicines, Innovation and the Future of Biotech with AION Labs CEO (Hebrew)

8200Bio BioNation Podcast with AION Labs CEO

AION Labs Launches Seeding Track with Promise Bio

AION Lab’s Promise Bio included in The 51 most disruptive startups of 2024

Promise Bio secures $8.3M in seed investment for immune-mediated diseases